Epidemiology of Antibiotic Resistant Pathogens in Pediatric Urinary Tract Infections as a Tool to Develop a Prediction Model for Early Detection of Drug-Specific Resistance.

antibiotic resistance pediatrics prediction model risk factors urinary tract infections

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
26 May 2022
Historique:
received: 20 04 2022
revised: 20 05 2022
accepted: 25 05 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 25 6 2022
Statut: epublish

Résumé

Antibiotic resistance is an increasing problem, especially in children with urinary tract infections. Rates of drug-specific resistant pathogens were reported, and an easy prediction model to guide the clinical decision-making process for antibiotic treatment was proposed. Data on microbiological isolation from urinoculture, between January 2007−December 2018 at Istituto Gaslini, Italy, in patients aged <19 years were extracted. Logistic regression-based prediction scores were calculated. Discrimination was determined by the area under the receiver operating characteristic curve; calibration was assessed by the Hosmer and Lemeshow test and the Spiegelhalterz test. A total of 9449 bacterial strains were isolated in 6207 patients; 27.2% were <6 months old at the first episode. Enterobacteriales (Escherichia coli and other Enterobacteriales) accounted for 80.4% of all isolates. Amoxicillin-clavulanate (AMC) and cefixime (CFI) Enterobacteriales resistance was 32.8% and 13.7%, respectively, and remained quite stable among the different age groups. On the contrary, resistance to ciprofloxacin (CIP) (overall 9.6%) and cotrimoxazole (SXT) (overall 28%) increased with age. After multivariable analysis, resistance to AMC/CFI could be predicted by the following: sex; age at sampling; department of admission; previous number of bacterial pathogens isolated. Resistance to CIP/SXT could be predicted by the same factors, excluding sex. The models achieved very good calibration but moderate discrimination performance. Specific antibiotic resistance among Enterobacteriales could be predicted using the proposed scoring system to guide empirical antibiotic choice. Further studies are needed to validate this tool.

Identifiants

pubmed: 35740127
pii: antibiotics11060720
doi: 10.3390/antibiotics11060720
pmc: PMC9220059
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministero della Salute
ID : Ricerca Corrente 2021

Références

Int J Antimicrob Agents. 2011 Dec;38 Suppl:42-50
pubmed: 22036250
Antibiotics (Basel). 2021 Oct 04;10(10):
pubmed: 34680787
N Engl J Med. 2009 Oct 29;361(18):1748-59
pubmed: 19864673
J Infect. 2003 Feb;46(2):94-100
pubmed: 12634070
Infect Drug Resist. 2021 Jun 23;14:2341-2348
pubmed: 34188500
JAMA Pediatr. 2019 Oct 01;173(10):949-952
pubmed: 31381021
Eur J Pediatr. 2016 Sep;175(9):1219-1225
pubmed: 27558493
Antimicrob Resist Infect Control. 2021 May 1;10(1):74
pubmed: 33933164
J Antimicrob Chemother. 2018 Jun 1;73(6):1700-1707
pubmed: 29394363
Pediatrics. 2018 Jul;142(1):
pubmed: 29954832
Pediatrics. 2016 Sep;138(3):
pubmed: 27542848
J Clin Pharmacol. 2016 Sep;56(9):1060-75
pubmed: 26865283
Acta Paediatr. 2020 Feb;109(2):236-247
pubmed: 31454101
J Pediatr Urol. 2017 Jun;13(3):306-315
pubmed: 28462806
J Pediatr Urol. 2017 Dec;13(6):567-573
pubmed: 28986090
Arch Dis Child. 2011 Sep;96(9):874-80
pubmed: 21785119
Ann Intern Med. 2015 Jan 6;162(1):W1-73
pubmed: 25560730
Drugs. 2018 Oct;78(15):1593-1604
pubmed: 30311096
Acta Paediatr. 2019 Mar;108(3):544-550
pubmed: 30028535
Pediatr Infect Dis J. 2020 Feb;39(2):121-126
pubmed: 31738320
Acta Paediatr. 2012 Oct;101(10):1018-31
pubmed: 22784016
J Paediatr Child Health. 2012 Apr;48(4):296-301
pubmed: 21199053
BMC Med. 2019 Dec 16;17(1):230
pubmed: 31842878
J Glob Antimicrob Resist. 2020 Mar;20:4-10
pubmed: 31252156
Pediatrics. 2016 Nov;138(5):
pubmed: 27940800
BMC Public Health. 2017 Nov 17;17(1):886
pubmed: 29149875
Pediatr Infect Dis J. 2020 Dec;39(12):1106-1110
pubmed: 33021597
J Urol. 2013 Jul;190(1):222-7
pubmed: 23369720
N Engl J Med. 2014 Jun 19;370(25):2367-76
pubmed: 24795142
J Pediatr. 2017 Mar;182:239-244.e1
pubmed: 28012694
BMJ Paediatr Open. 2019 Sep 24;3(1):e000487
pubmed: 31646191
JAMA Pediatr. 2016 Sep 1;170(9):848-54
pubmed: 27455161
Epidemiology. 2010 Jan;21(1):128-38
pubmed: 20010215
Expert Opin Pharmacother. 2017 Oct;18(15):1619-1625
pubmed: 28954556
Nat Med. 2019 Jul;25(7):1143-1152
pubmed: 31273328
BMJ. 2016 Mar 15;352:i939
pubmed: 26980184
J Pediatr (Rio J). 2020 Mar - Apr;96 Suppl 1:65-79
pubmed: 31783012
Stat Med. 2004 May 30;23(10):1631-60
pubmed: 15122742

Auteurs

Francesca Bagnasco (F)

Scientific Directorate, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.

Giorgio Piaggio (G)

Division of Nephrology, Dialysis, and Transplantation, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.

Alessio Mesini (A)

Infectious Disease Unit, Department of Pediatrics, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.

Marcello Mariani (M)

Infectious Disease Unit, Department of Pediatrics, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, 16132 Genova, Italy.

Chiara Russo (C)

Infectious Diseases Unit, Ospedale Policlinico San Martino IRCCS, 16132 Genova, Italy.

Carolina Saffioti (C)

Infectious Disease Unit, Department of Pediatrics, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.

Giuseppe Losurdo (G)

Infectious Disease Unit, Department of Pediatrics, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.

Candida Palmero (C)

Clinical Pathology Laboratory and Microbiology, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.

Elio Castagnola (E)

Infectious Disease Unit, Department of Pediatrics, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.

Classifications MeSH